Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cutting Edge: Metabolic Immune Reprogramming, Reactive Oxygen Species, and Cancer Publisher Pubmed



Aria H1 ; Ghaedrahmati F1 ; Ganjalikhanihakemi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Cellular Physiology Published:2021


Abstract

A recently proposed term “immunometabolism” points to the functional intracellular metabolic changes that occur within different immune cells. Recent findings suggest that immune responses can be determined by the metabolic status of immune cells and metabolic reprogramming is an important feature of immune cell activation. Metabolic reprogramming is also well known for cancer cells and has been suggested as a major sign of cancer progression. Metabolic reprogramming of immune cells is also seen in the tumor microenvironment. In the past decade, immunometabolism has progressively become an extraordinarily vibrant and productive area of study in immunology because of its importance for immunotherapy. Understanding the immunometabolic situation of T cells and other immune cells along with the metabolic behavior of cancer cells can help us design new therapeutic approaches against cancers. Here, we have the aim to review the cutting-edge findings on the immunometabolic situation in immune and tumor cells. We discuss new findings on signaling pathways during metabolic reprogramming, its regulation, and the participation of reactive oxygen species in these processes. © 2021 Wiley Periodicals LLC
Related Docs
View other Related Docs
1. Tim-3/Gal-9 Interaction Affects Glucose and Lipid Metabolism in Acute Myeloid Leukemia Cell Lines, Frontiers in Immunology (2023)
2. Purinergic Receptors Are a Key Bottleneck in Tumor Metabolic Reprogramming: The Prime Suspect in Cancer Therapeutic Resistance, Frontiers in Immunology (2022)
3. The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies, Frontiers in Oncology (2021)
4. Digging Deeper Through Glucose Metabolism and Its Regulators in Cancer and Metastasis, Life Sciences (2021)
5. The Role of Hypoxia in the Tumor Microenvironment and Development of Cancer Stem Cell: A Novel Approach to Developing Treatment, Cancer Cell International (2021)
6. Immunomodulatory Effects of Flavonoids: Possible Induction of T Cd4+ Regulatory Cells Through Suppression of Mtor Pathway Signaling Activity, Frontiers in Immunology (2019)
7. Regulating the Regulatory T Cells As Cell Therapies in Autoimmunity and Cancer, Frontiers in Medicine (2023)
8. The Role of Distinct Subsets of Macrophages in the Pathogenesis of Ms and the Impact of Different Therapeutic Agents on These Populations, Frontiers in Immunology (2021)
Experts (# of related papers)
View all Related Experts
Mazdak Ganjalikhani Hakemi (4)
Marzieh Rezaei (2)
Other Related Docs
9. Immunologic Tumor Microenvironment Modulators for Turning Cold Tumors Hot, Cancer Communications (2024)
10. Immunometabolism Dysfunction in the Pathophysiology and Treatment of Rheumatoid Arthritis, Current Medicinal Chemistry (2023)
11. The Role of Tim-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?, Frontiers in Oncology (2020)
12. The Pro-Tumorigenic Responses in Metastatic Niches: An Immunological Perspective, Clinical and Translational Oncology (2023)
13. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
14. Breast Feeding, Obesity, and Asthma Association: Clinical and Molecular Views, Clinical and Molecular Allergy (2023)
15. Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor As a Pleiotropic Cytokine, Breast Cancer: Basic and Clinical Research (2024)
16. Involvement of Aberrant Regulation of Epigenetic Mechanisms in the Pathogenesis of Parkinson's Disease and Epigenetic-Based Therapies, Journal of Cellular Physiology (2019)
17. Glioblastoma and Chemoresistance to Alkylating Agents: Involvement of Apoptosis, Autophagy, and Unfolded Protein Response, Pharmacology and Therapeutics (2018)
18. Don't Eat Me/Eat Me Signals As a Novel Strategy in Cancer Immunotherapy, Heliyon (2023)
19. The Role of Bone Marrow Microenvironment (Bmm) Cells in Acute Myeloid Leukemia (Aml) Progression: Immune Checkpoints, Metabolic Checkpoints, and Signaling Pathways, Cell Communication and Signaling (2023)
20. Natural Ampk Activators in Cardiovascular Disease Prevention, Frontiers in Pharmacology (2022)
21. Immune Checkpoint Inhibitors As Mediators for Immunosuppression by Cancer-Associated Fibroblasts: A Comprehensive Review, Frontiers in Immunology (2022)
22. Novel Insights Into the Role of Circular Rnas in Parkinson Disease: An Emerging Renaissance in the Management of Neurodegenerative Diseases, Journal of Neuroscience Research (2022)
23. Pd-L1 Stimulation Can Promote Proliferation and Survival of Leukemic Cells by Influencing Glucose and Fatty Acid Metabolism in Acute Myeloid Leukemia, BMC Cancer (2023)